BioRestorative Therapies, Inc. - BRTX

SEC Filings Our BRTX Tweets

About Gravity Analytica

Recent News

  • 09.02.2026 - BioRestorative Therapies Announces Reverse Stock Split
  • 06.25.2026 - BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
  • 06.25.2026 - BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
  • 06.18.2026 - BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
  • 06.18.2026 - BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
  • 05.26.2026 - BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
  • 05.26.2026 - BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
  • 05.13.2026 - BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals
  • 05.13.2026 - BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals
  • 05.07.2026 - BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease

Recent Filings

  • 09.02.2026 - 8-K Current report
  • 09.02.2026 - 8-K Current report
  • 09.02.2026 - EX-99.1 EX-99.1
  • 08.25.2026 - 8-K Current report
  • 08.14.2026 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
  • 08.14.2026 - 8-K Current report
  • 08.03.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 07.30.2026 - 3 Initial statement of beneficial ownership of securities
  • 07.24.2026 - 3 Initial statement of beneficial ownership of securities
  • 07.16.2026 - 8-K Current report